Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101)
Clinical trial NCT02584634 · TERMINATED
Trial details
- NCT number
- NCT02584634
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-18
- Primary completion
- 2021-02-02
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.